Clinical TrialsSearch results
Number of results: 189
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
- Asthma
- Jain Neal
- 2024-05-27
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
- Acute coronary syndrome
- Sanofi K.K.
- 2008-05-10
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy
- Advanced or recurrent gastric cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-08-31
Other
- A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
- patients with high risk group of endometrial carcinoma which is removed surgically
- Japanese Gynecologic Oncology Group
- 2006-11-15